Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Mice with the ab gene have abnormal sebaceous gland development, affecting sebum production.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

The document is a detailed medical reference on skin and genetic disorders.

The document explains various skin conditions and their treatments.

Genetic mutations can affect female sexual development, requiring personalized medical care.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Using steroids can increase the risk of heart problems.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Accurate diagnosis is crucial to distinguish between PCOS and rare ovarian tumors in teens with similar symptoms.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

The absence of functional sebaceous glands causes hair follicle destruction and scarring alopecia.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.